Search Results

Training Programs

A wide range of training opportunities are available for students and fellows, including the Post-Baccalaureate Training Program and the Patient-Centered Pediatric Research Program.

Article

November 2013

Dr. Louis Chicoine discusses the effect of plasmapheresis in removal of AAV antibodies for gene therapy.

Responding to the Crisis of Black Youth Suicide

Research over the last decade has shown a troubling increase in suicidal thoughts and attempts among young Black people. But little research exists on the “how” and “why” of suicide in Black youth.

Article

National Health IT Week

For the second time, Nationwide Children's Hospital celebrated National Health IT Week to show how Information Technology employees are helping transform healthcare at Nationwide Children's Hospital.

Article

Zhao Lab Staff

Learn more about principal investigator Mingtao Zhao, DVM, PhD, and his dynamic team in the Zhao Lab.

Specialty

Center for Pediatric Trauma Research

Established in 2013, the Center for Pediatric Trauma Research at Nationwide Children’s Hospital conducts research to achieve best outcomes for pediatric trauma patients.

Article

Baker Lab Staff

Learn more about principal investigator Linda Baker, MD, and her dynamic team in the Baker Lab.

News

Understanding Black Youth Suicide: Steps Toward Prevention

In a statement published in JAMA Pediatrics, researchers at the Nationwide Children’s Hospital, the University of North Carolina at Chapel Hill and the nonprofit research institute RTI International responded to a call from the National Institute of Mental Health (NIMH) requesting information on how to prevent Black youth suicide. The researchers emphasize the need for research and action of suicide prevention among Black youth must start from the ground up.

Article

Bakaletz Lab

The Bakaletz Lab, led by Lauren Bakaletz, PhD, has been funded for over 25 years to study the pathogenesis, prevention and treatment of diseases. The primary focus of the lab’s work has been to design and test vaccine candidates that can prevent and/or resolve otitis media, or middle ear infection, and exacerbations of chronic obstructive pulmonary disease (COPD).